Daniel Joseph McCarthy - 01 Mar 2026 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2026, 17:53:20 UTC
Prior SEC filing
03 Jul 2025
Next SEC filing
06 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Weinberg, Attorney-in-fact

Key filing fact

Daniel Joseph McCarthy filed Form 4 for Evolent Health, Inc. (EVH) on 04 Mar 2026.

Key facts

  • This page summarizes Daniel Joseph McCarthy's Form 4 filing for Evolent Health, Inc. (EVH).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Mar 2026, 17:53.

Change

  • Previous filing in this sequence was filed on 03 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001946147 Primary reporting owner

McCarthy Daniel Joseph

Relationship
PRESIDENT
Address
C/O EVOLENT HEALTH, INC., 1812 N. MOORE ST., STE. 1705, ARLINGTON
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Signature date
04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVH transaction

Class A Common Stock

Tax liability

Transaction value
Shares
-7,811
Change %
-1.8%
Price
$3.25*
Shares after
425,960
Date
01 Mar 2026
Ownership
Direct
Footnotes
F1, F2
EVH transaction

Class A Common Stock

Award

Transaction value
Shares
+39,281
Change %
+9.2%
Price
$0.000000*
Shares after
465,241
Date
02 Mar 2026
Ownership
Direct
Footnotes
F2, F3
EVH transaction

Class A Common Stock

Tax liability

Transaction value
Shares
-18,192
Change %
-3.9%
Price
$3.58*
Shares after
447,049
Date
02 Mar 2026
Ownership
Direct
Footnotes
F2, F4
EVH transaction

Class A Common Stock

Tax liability

Transaction value
Shares
-24,027
Change %
-5.4%
Price
$3.51*
Shares after
423,022
Date
03 Mar 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVH transaction Derivative

Performance-Based Share Unit

Award

Transaction value
Shares
+826,440
Change %
Price
$0.000000*
Shares after
826,440
Date
02 Mar 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
826,440
Exercise price
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

Footnote F2

Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

Footnote F3

Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025.

Footnote F4

This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.

Footnote F5

Represents performance-based share units (PSUs) granted to Mr. McCarthy pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .